Serotype-Specific Killing of Large Cell Carcinoma Cells by Reovirus

Reovirus is under development as a therapeutic for numerous types of cancer. In contrast to other oncolytic viruses, the safety and efficacy of reovirus have not been improved through genetic manipulation. Here, we tested the oncolytic capacity of recombinant strains (rs) of prototype reovirus labor...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Emily J., Howells, Morgan A., Stuart, Johnasha D., Boehme, Karl W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490817/
https://www.ncbi.nlm.nih.gov/pubmed/28587298
http://dx.doi.org/10.3390/v9060140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490817/
https://www.ncbi.nlm.nih.gov/pubmed/28587298
http://dx.doi.org/10.3390/v9060140

Ejemplares similares